HIV & AIDS

Recombinase Brec1 trend-setting for future HIV therapy

Researchers at the Medical Faculty of the Technische Universität Dresden (TUD) and the Heinrich Pette Institute (HPI), Leibniz Institute for Experimental Virology succeeded in developing a designer recombinase (Brec1) that ...

HIV & AIDS

Researchers describe first 'functional HIV cure' in an infant

A team of researchers from Johns Hopkins Children's Center, the University of Mississippi Medical Center and the University of Massachusetts Medical School describe the first case of a so-called "functional cure" in an HIV-infected ...

HIV & AIDS

Brain cells can harbor and spread HIV virus to the body

Researchers have found that astrocytes, a type of brain cell can harbor HIV and then spread the virus to immune cells that traffic out of the brain and into other organs. HIV moved from the brain via this route even when ...

HIV & AIDS

New drug capsule may allow weekly HIV treatment

Researchers at MIT and Brigham and Women's Hospital have developed a capsule that can deliver a week's worth of HIV drugs in a single dose. This advance could make it much easier for patients to adhere to the strict schedule ...

HIV & AIDS

Results of 'highly significant' HIV transmission study published

A new Liverpool led study, published in The Lancet HIV, addresses an important knowledge gap around the management of women who start HIV treatment in late pregnancy, with the ultimate aim of reducing mother to child transmission ...

HIV & AIDS

Researchers take another big step toward HIV cure

Today, HIV can be managed with medical treatment. However, despite 40 years of intensive research, scientists have not yet succeeded in finding a cure for the disease. People with HIV experience a flare-up of the virus only ...

page 3 from 39